TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27736846

Group type: EXPERIMENTAL
Intervention: Paclitaxel treatment
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: CYP2C8*3 carriers
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: FGD4 c.2044‐236 A‐allele carriers
Number of subjects: 188
Study: 25290151

Group type: EXPERIMENTAL
Intervention: Capsaicin 8% patch
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 46
Study: 22845420

Group type: EXPERIMENTAL
Intervention: Diazoxide
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no diazoxide)
Number of subjects: 16
Study: 20236342

Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg
Number of subjects: 346

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 346
Study: 17635371

Group type: EXPERIMENTAL
Intervention: Peginterferon alpha-2a, 180 microg once weekly
Number of subjects: 22

Group type: COMPARATOR
Intervention: Peginterferon alpha-2b, 1.0 microg/kg once weekly
Number of subjects: 22
Study: 16079391

Group type: EXPERIMENTAL
Intervention: Cognitive training and supported employment (CT + SE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Supported employment only (SE Only)
Number of subjects: 44
Study: 12106717

Group type: EXPERIMENTAL
Intervention: AR40e intraocular lens (IOL)
Number of subjects: 53

Group type: COMPARATOR
Intervention: AR40 intraocular lens (IOL)
Number of subjects: 53

Group type: COMPARATOR
Intervention: AR40 IOL
Number of subjects: 53
Study: 10094741

Group type: EXPERIMENTAL
Intervention: Endoscopic tension-free inguinal hernia repair
Number of subjects: 64

Group type: COMPARATOR
Intervention: Open tension-free inguinal hernia repair
Number of subjects: 64
Study: 7828129

Group type: EXPERIMENTAL
Intervention: Radiotherapy alone (RT)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy and surgery (RS)
Number of subjects: 185
Study: 2156883

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (60% carbohydrate and 25% fat)
Number of subjects: 16

Group type: COMPARATOR
Intervention: High fat diet (50% fat and 35% carbohydrate)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet
Number of subjects: 16

Group type: COMPARATOR
Intervention: High fat diet
Number of subjects: 16
Study: 31464923

Group type: EXPERIMENTAL
Intervention: Comprehensive Care and Rehabilitation Program (CCRP)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 240
Study: 29984258

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 60
Study: 28445888

Group type: EXPERIMENTAL
Intervention: Inflammatory stress (typhoid vaccination)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Psychosocial stress (Trier Social Stress Test [TSST])
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Combination of inflammatory and psychosocial stress
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Vaccination
Number of subjects: 39
Study: 24521180

Group type: EXPERIMENTAL
Intervention: Community pharmacists (inexperienced in medication review) after receiving 2-day training in medication review
Number of subjects: 155

Group type: COMPARATOR
Intervention: Expert reviewers
Number of subjects: 155
Study: 22204993

Group type: EXPERIMENTAL
Intervention: Antithrombin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Gabexate mesilate
Number of subjects: 16
Study: 20181387

Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl followed by 17% EDTA
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1.3% NaOCl followed by 17% EDTA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1.3% NaOCl
Number of subjects: 0
Study: 17034812

Group type: EXPERIMENTAL
Intervention: Context training (words presented in stories)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isolated word training (words presented on flashcards)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transfer task employed at test
Number of subjects: 0
Study: 15811899

Group type: EXPERIMENTAL
Intervention: medicines organizer (MO)
Number of subjects: 62

Group type: COMPARATOR
Intervention: standard packaging
Number of subjects: 62
Study: 12410941

Group type: EXPERIMENTAL
Intervention: Collagen membrane
Number of subjects: 17

Group type: COMPARATOR
Intervention: e‐PTFE membrane
Number of subjects: 17
Study: 9608966

Group type: EXPERIMENTAL
Intervention: Trachlight lighted stylet
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Surch-Lite lighted stylet
Number of subjects: 18

Group type: COMPARATOR
Intervention: Regular tracheal tube stylet
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All devices
Number of subjects: 18
Study: 8579878

Group type: EXPERIMENTAL
Intervention: 120‐hour continuous infusion 5‐Fu and bolus cisplatin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 36
Study: 2116667

Group type: EXPERIMENTAL
Intervention: Thromboembolism prophylaxis with heparin
Number of subjects: 303
Study: 567007

Group type: EXPERIMENTAL
Intervention: Plant protein diet (soy protein meat analogues and soy milk)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Conventional diet containing mixed protein
Number of subjects: 11
Study: 31017315

Group type: EXPERIMENTAL
Intervention: Upper ministernotomy (M group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional sternotomy (C group)
Number of subjects: 100
Study: 28873075

Group type: EXPERIMENTAL
Intervention: Magnesium infusion (30 mg/kg in the first hour followed by 9 mg/kg/h until the end of the surgical procedure)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Magnesium infusion
Number of subjects: 294

Group type: COMPARATOR
Intervention: Control (0.9% saline at the same volume and rate)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 294
Study: 25848773

Group type: EXPERIMENTAL
Intervention: rtfMRI neurofeedback (true feedback from rostral anterior cingulate cortex)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham neurofeedback (sham feedback from posterior cingulate cortex)
Number of subjects: 16
Study: 23523255

Group type: EXPERIMENTAL
Intervention: Diacutaneous Fibrolysis
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham Diacutaneous Fibrolysis
Number of subjects: 120

Group type: COMPARATOR
Intervention: Protocolised treatment (control)
Number of subjects: 120
Study: 21241374

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: PUVA
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (healthy volunteers)
Number of subjects: 24
Study: 18157018

Group type: EXPERIMENTAL
Intervention: Propofol (5.7±0.2 mg/kg/h)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 30
Study: 15988813

Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 54

Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 54
Study: 12406823

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 1,000 microg/day
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 244
Study: 10333200

Group type: EXPERIMENTAL
Intervention: Budesonide (3 x 1 mg oral pH‐modified release)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 83
Study: 7475656

Group type: EXPERIMENTAL
Intervention: CABG (coronary artery bypass grafting)
Number of subjects: 1054

Group type: COMPARATOR
Intervention: PTCA (percutaneous transluminal coronary angioplasty)
Number of subjects: 1054

Group type: COMPARATOR
Intervention: PTCA
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1054
Study: 1939676

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Supportive therapy (Control)
Number of subjects: 25
Study: 7230083

Group type: EXPERIMENTAL
Intervention: Named stimulus pretraining condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unnamed stimulus pretraining condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dactylo-kinesthetic (fingerspelled) stimulus pretraining condition
Number of subjects: 0
Study: 29020689

Group type: EXPERIMENTAL
Intervention: Transpancreatic precut papillotomy (TPPP)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Double-guidewire technique (DGT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Both TPPP and DGT
Number of subjects: 68
Study: 28575774

Group type: EXPERIMENTAL
Intervention: Manual-based psychosocial group intervention (6 weekly 2-hour sessions)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 83
Study: 26262903

Group type: EXPERIMENTAL
Intervention: Risperidone (mean 2.47mg/day, S.D. 1.29mg)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 84
Study: 24038561

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Simvastatin 40 mg daily
Number of subjects: 30
Study: 20843236

Group type: EXPERIMENTAL
Intervention: 0.4% moxifloxacin gel
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 1.25% moxifloxacin gel
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 0.125% moxifloxacin gel
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 57
Study: 18162659

Group type: EXPERIMENTAL
Intervention: Firsthand experience of a situation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No firsthand experience of a situation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Holier-than-thou biases
Number of subjects: 0
Study: 16789449

Group type: EXPERIMENTAL
Intervention: Silver coated pins (SC)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Stainless steel pins (SS)
Number of subjects: 19
Study: 15388302

Group type: EXPERIMENTAL
Intervention: Full narration (verbal information during demonstration and test)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Empty narration (no verbal information)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal cues only at the time of retrieval
Number of subjects: 0

Group type: COMPARATOR
Intervention: Verbal cues only at the time of original encoding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Verbal cues presented only at the time of original encoding
Number of subjects: 0
Study: 11303414

Group type: EXPERIMENTAL
Intervention: Emedastine 0.05% twice daily for 42 days
Number of subjects: 221

Group type: COMPARATOR
Intervention: Levocabastine 0.05% twice daily for 42 days
Number of subjects: 221
Study: 9247526

Group type: EXPERIMENTAL
Intervention: Amiodarone (800 mg/day for 14 days, 400 mg/day for 50 weeks, then 300 mg/day thereafter)
Number of subjects: 519

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Amiodarone (in patients with COPD)
Number of subjects: 519

Group type: COMPARATOR
Intervention: Placebo (in patients with COPD)
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 519
Study: 8273226

Group type: EXPERIMENTAL
Intervention: Preincisional lidocaine infiltration (1% lidocaine, 40 ml)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Postincisional lidocaine infiltration (1% lidocaine, 40 ml)
Number of subjects: 37
Study: 3542342

Group type: EXPERIMENTAL
Intervention: L-adrenaline infusion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Salbutamol infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 8
Study: 30390699

Group type: EXPERIMENTAL
Intervention: Low protein breakfast (12.4% protein)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Medium protein breakfast (23.5% protein)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: High protein breakfast (40.6% protein)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Ad libitum meal after breakfast
Number of subjects: 22
Study: 27842939

Group type: EXPERIMENTAL
Intervention: High-dose baclofen (up to 150mg)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Low-dose baclofen (30mg)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 24897342

Group type: EXPERIMENTAL
Intervention: Red yeast rice
Number of subjects: 804

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 804
Study: 22608583

Group type: EXPERIMENTAL
Intervention: Sugammadex 2 mg/kg
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Sugammadex 4 mg/kg
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Sugammadex (both doses)
Number of subjects: 77
Study: 20465440

Group type: EXPERIMENTAL
Intervention: Repeated applanation tonometry measurements in glaucoma patients
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (patients scheduled for cataract surgery)
Number of subjects: 67
Study: 18684280

Group type: EXPERIMENTAL
Intervention: Programmed AVD of 60-160 ms during CRT
Number of subjects: 30
Study: 16182720

Group type: EXPERIMENTAL
Intervention: Vitamin supplementation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 56
Study: 14716113

Group type: EXPERIMENTAL
Intervention: Chemoradiation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Radiation treatment (Control)
Number of subjects: 50
Study: 11061483

Group type: EXPERIMENTAL
Intervention: Individual counseling by a doctor with a five-month intervention
Number of subjects: 263

Group type: COMPARATOR
Intervention: Equivalent delayed intervention for four months
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Overall smoking cessation intervention
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Long-term survey of those who succeeded in quitting
Number of subjects: 263
Study: 8642232

Group type: EXPERIMENTAL
Intervention: Metoprolol (5 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Enalaprilat (2 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 7
Study: 8460795

Group type: COMPARATOR
Intervention: Halothane anaesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isoflurane anaesthesia
Number of subjects: 40
Study: 4027636

Group type: EXPERIMENTAL
Intervention: Helium-neon laser (632.5 nm, 1 mW, 20 Hz)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 21
Study: 29654560

Group type: EXPERIMENTAL
Intervention: Low-concentration contrast medium (LC-CM) with iodixanol 270
Number of subjects: 65

Group type: COMPARATOR
Intervention: High-concentration contrast medium (HC-CM) with iopromide 370
Number of subjects: 65
Study: 27631987

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection by physiotherapist
Number of subjects: 64

Group type: COMPARATOR
Intervention: Corticosteroid injection by orthopaedic surgeon
Number of subjects: 64
Study: 23523130

Group type: EXPERIMENTAL
Intervention: CM+CBT
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: CM
Number of subjects: 82

Group type: COMPARATOR
Intervention: CBT
Number of subjects: 82
Study: 21148046

Group type: EXPERIMENTAL
Intervention: Honey (2 × 20 g/d)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Artificial honey (2 × 20 g/d)
Number of subjects: 20
Study: 19220941

Group type: EXPERIMENTAL
Intervention: Procedure-specific consent forms (PSCF)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional consent forms
Number of subjects: 100
Study: 17482078

Group type: EXPERIMENTAL
Intervention: Unilateral distalization with a modified pendulum appliance
Number of subjects: 15
Study: 15273582

Group type: EXPERIMENTAL
Intervention: Oral metronidazole with paper diary
Number of subjects: 71

Group type: COMPARATOR
Intervention: Oral metronidazole with PDA
Number of subjects: 71

Group type: COMPARATOR
Intervention: PDA versus paper diary compliance agreement
Number of subjects: 71
Study: 11520717

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF-DPI) 50 microg, twice daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF-DPI) 100 microg, twice daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF-DPI) 400 microg, twice daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9817274

Group type: EXPERIMENTAL
Intervention: FDG-PET
Number of subjects: 36

Group type: COMPARATOR
Intervention: CT
Number of subjects: 36
Study: 7840022

Group type: EXPERIMENTAL
Intervention: Biologically standardized extract of mites (active therapy)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Saline buffered solution (placebo)
Number of subjects: 58
Study: 3042932

Group type: EXPERIMENTAL
Intervention: Detailed discussion with the patient's physician about decision making and life support therapy in the event of extreme or incapacitating illness.
Number of subjects: 74
Study: 30653978

Group type: EXPERIMENTAL
Intervention: Metformin therapy
Number of subjects: 1982

Group type: COMPARATOR
Intervention: No Metformin therapy
Number of subjects: 1982
Study: 28807189

Group type: EXPERIMENTAL
Intervention: Incentives for couples' HIV testing and counselling (CHTC) - participants could select one of three grocery items worth US$1.50.
Number of subjects: 24679

Group type: COMPARATOR
Intervention: Standard mobilisation for testing (comparison group).
Number of subjects: 24679

Group type: EXPERIMENTAL
Intervention: Incentives for CHTC.
Number of subjects: 24679

Group type: EXPERIMENTAL
Intervention: Telephone survey post-CHTC.
Number of subjects: 24679
Study: 26272712

Group type: EXPERIMENTAL
Intervention: Vertebroplasty (VP)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 23377836

Group type: EXPERIMENTAL
Intervention: Intermittent physical activity (5 min every 30 min, 17 times)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Continuous physical activity (40 min and then 45 min)
Number of subjects: 9
Study: 21943403

Group type: EXPERIMENTAL
Intervention: Home relapse management
Number of subjects: 138

Group type: COMPARATOR
Intervention: Hospital relapse management
Number of subjects: 138
Study: 18430270

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1600
Study: 21519230

Group type: EXPERIMENTAL
Intervention: Risk quantification model for 30-day postoperative mortality
Number of subjects: 635265

Group type: EXPERIMENTAL
Intervention: Risk quantification model for 30-day postoperative morbidity
Number of subjects: 635265
Study: 15375668

Group type: EXPERIMENTAL
Intervention: Gentamycin collagen sponge (GRM(+))
Number of subjects: 229

Group type: COMPARATOR
Intervention: Control group (GRM(-))
Number of subjects: 229
Study: 11855540

Group type: COMPARATOR
Intervention: 20 mg omeprazole at 08:00 hr followed by placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 75 mg ranitidine at 22:00 hr
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole at 22:00 hr
Number of subjects: 16
Study: 9665596

Group type: EXPERIMENTAL
Intervention: Riluzole 50 mg bid for 3 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison of treated vs untreated
Number of subjects: 23
Study: 7647826

Group type: EXPERIMENTAL
Intervention: Plantago ovata preparation (20 g granules with 200 ml water)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (20 g granules with 200 ml water)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Water (200 ml)
Number of subjects: 17
Study: 2772857

Group type: EXPERIMENTAL
Intervention: Supine posture for four hours
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sitting upright for four hours
Number of subjects: 9
Study: 325342

Group type: EXPERIMENTAL
Intervention: delta9-tetrahydrocannabinol (THC) 15 MG/70 KG
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ethanol 0-54 g/kg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination of THC and Ethanol
Number of subjects: 15
Study: 29993259

Group type: EXPERIMENTAL
Intervention: Jidabokuippo (JDI) 7.5 g
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study: 27311074

Group type: EXPERIMENTAL
Intervention: Lundborg's method
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Sirotakova's method
Number of subjects: 38
Study: 24114079

Group type: EXPERIMENTAL
Intervention: End-tidal-controlled anaesthesia (EtCA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Manually-controlled anaesthesia (MCA)
Number of subjects: 80
Study: 21933201

Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 30
Study: 20391509

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Denosumab 180 mg
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study: 18482303

Group type: EXPERIMENTAL
Intervention: Multifactorial fall prevention program (staff and resident education, environmental adaptations, hip protectors, balance and resistance training)
Number of subjects: 725

Group type: EXPERIMENTAL
Intervention: Multifactorial fall prevention program
Number of subjects: 725
Study: 15835228

Group type: EXPERIMENTAL
Intervention: pH-balanced cleanser
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 0
Study: 12627404

Group type: COMPARATOR
Intervention: Various doses of a drug
Number of subjects: 0
Study: 10390007

Group type: EXPERIMENTAL
Intervention: ECF regimen (epirubicin, cisplatin, and protracted venous infusion fluorouracil)
Number of subjects: 274

Group type: COMPARATOR
Intervention: FAMTX (5‐FU, doxorubicin, and methotrexate)
Number of subjects: 274
Study: 8735024

Group type: EXPERIMENTAL
Intervention: ProtoVIEW (computer-based protocol consultation)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Paper-based protocol consultation (control)
Number of subjects: 8
Study: 2006742

Group type: EXPERIMENTAL
Intervention: Continuous infusion of 0.25% bupivacaine at 0.125 mL.kg‐1.h‐1 (n = 13)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Repeated bolus injections of 0.5% bupivacaine with epinephrine 1:200,000 at 0.4 mL/kg every sixth hour (n = 12)
Number of subjects: 25
Study: 7331659

Group type: EXPERIMENTAL
Intervention: Jejunoileal bypass surgery with a 3:1 jejunal to ileal ratio
Number of subjects: 13

Group type: COMPARATOR
Intervention: Jejunoileal bypass surgery with a 1:3 jejunal to ileal ratio
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Post-surgery (both groups)
Number of subjects: 13
Study: 31165721

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional physical therapy
Number of subjects: 28